Search Results - "de Leeuw, Lidewij R."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice

    LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice by Hoekstra, Menno, de Jong, Laura M, van der Geest, Rick, de Leeuw, Lidewij R, Krisnamurthi, Rani, Geerling, Janine J, Van Eck, Miranda

    Published in Biomolecules (Basel, Switzerland) (01-04-2024)
    “…Preclinical studies regarding the potential of liver X receptor (LXR) agonists to inhibit macrophage foam cell formation and the development of atherosclerotic…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression

    Juvenile Arthritis Patients Suffering from Chronic Inflammation Have Increased Activity of Both IDO and GTP-CH1 Pathways But Decreased BH4 Efficacy: Implications for Well-Being, Including Fatigue, Cognitive Impairment, Anxiety, and Depression by Korte-Bouws, Gerdien A H, Albers, Eline, Voskamp, Marije, Hendriksen, Hendrikus, de Leeuw, Lidewij R, Güntürkün, Onur, de Roock, Sytze, Vastert, Sebastiaan J, Korte, S Mechiel

    Published in Pharmaceuticals (Basel, Switzerland) (08-01-2019)
    “…Juvenile idiopathic arthritis (JIA) represents joint inflammation with an unknown cause that starts before the age of 16, resulting in stiff and painful…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice

    Inhibition of PRMT3 activity reduces hepatic steatosis without altering atherosclerosis susceptibility in apoE knockout mice by Hoekstra, Menno, Nahon, Joya E., de Jong, Laura M., Kröner, Mara J., de Leeuw, Lidewij R., Van Eck, Miranda

    “…The nuclear receptor liver X receptor (LXR) impacts on cholesterol metabolism as well as hepatic lipogenesis via transcriptional regulation. It is proposed…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Abca1 deficiency protects the heart against myocardial infarction-induced injury

    Abca1 deficiency protects the heart against myocardial infarction-induced injury by Louwe, Mieke C, Lammers, Bart, Frias, Miguel A, Foks, Amanda C, de Leeuw, Lidewij R, Hildebrand, Reeni B, Kuiper, Johan, Smit, Johannes W.A, Van Berkel, Theo J.C, James, Richard W, Geerling, Janine J, Rensen, Patrick C.N, Van Eck, Miranda

    Published in Atherosclerosis (01-08-2016)
    “…Abstract Background and aims We explored the role of ATP-binding cassette transporter A1 (Abca1), in post-myocardial infarction (MI) cardiac injury. Methods In…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice

    LXR Agonist T0901317's Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice by Hoekstra, Menno, de Jong, Laura M, van der Geest, Rick, de Leeuw, Lidewij R, Krisnamurthi, Rani, Geerling, Janine J, Van Eck, Miranda

    Published in Biomolecules (Basel, Switzerland) (02-04-2024)
    “…Preclinical studies regarding the potential of liver X receptor (LXR) agonists to inhibit macrophage foam cell formation and the development of atherosclerotic…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: